A comprehensive approach to the treatment of uterine leiomyomata

Mount Sinai Journal of Medicine

Volumn 76, Issue 6, 2009, Pages 546-556

  Stein, Karen ^a   Ascher Walsh, Charles ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alternative therapies; Fibroid; Hysterectomy; Myoma; Myomectomy; Treatment

Indexed keywords

AROMATASE INHIBITOR; CONTRACEPTIVE AGENT; ESTROGEN; GESTAGEN; GONADORELIN AGONIST; HEMOGLOBIN; IRON; LEUPRORELIN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; PLACEBO; PROGESTERONE RECEPTOR MODULATOR; RALOXIFENE; SOMATOMEDIN C;

ADVERSE DRUG REACTION; AMENORRHEA; ARTIFICIAL EMBOLISM; BLEEDING; CELL PROLIFERATION; CLINICAL TRIAL; DRUG MEGADOSE; DYSMENORRHEA; FERTILITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOESTROGENISM; HYSTERECTOMY; LAPAROSCOPY; MENOPAUSE; MENORRHAGIA; MYOMECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PSEUDOMENOPAUSE; QUALITY OF LIFE; QUESTIONNAIRE; RADIOFREQUENCY ABLATION; REVIEW; SAFETY; UNSPECIFIED SIDE EFFECT; UPREGULATION; UTERINE ARTERY EMBOLIZATION; UTERUS MYOMA;

ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; CATHETER ABLATION; CONTRACEPTIVE AGENTS; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; HYSTERECTOMY; HYSTEROSCOPY; LAPAROSCOPY; LEIOMYOMATOSIS; MYOMETRIUM; UTERINE NEOPLASMS;

EID: 73349103755     PISSN: 00272507     EISSN: 19317581     Source Type: Journal    
DOI: 10.1002/msj.20145     Document Type: Review

References (42)

1. Katz VS, Lentz G, Lobo R, Gershenson D. Comprehensive Gynecology. 5th ed. Philadelphia, PA: Mosby-Elsevier; 2007.
2. American College of Obstetricians and Gynecologists. Alternatives to hysterectomy in the management of leiomyomas. ACOG practice bulletin no. 96. Obstet Gynecol 2008; 112: 387-400.
3. Maruo T, Ohara N, Matsuo H, et al. Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas. Contraception 2005; 75: S99-S103.
4. Venkatachalam S, Bagratee JS, Moodley J. Medical management of uterine fibroids with medroxyprogesterine acetate (Depo Provera): a pilot study. J Obstet Gynaecol 2004; 24: 798-800.
5. Grigorieva V, Chen-Mok M, Tarasova M, Mikhailov A. Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril 2003; 79: 1194-1198.
6. Mercorio F, De Simone R, Di Speiezio Sardo A, et al. The effect of levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia. Contraception 2003; 67: 277-280.
7. Magalhaes J, Mendes Aldrighi J, Rodrigues de Lima G. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception 2007; 75: 193-198.
8. Mirena Healthcare Professionals. Placement & removal instructions. Available at: http://www.mirenaus. com/physician/placement.html. Accessed September 2009.
9. Palomba S, Orio FJr, Russo T, et al. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas. Hum Reprod 2004; 19: 1308-1314.
10. Vercellini P, Trespidi L, Zaina B, et al. Gonadotropinreleasing hormone agonist treatment before abdominal myomectomy: a controlled trial. Fertil Steril 2003; 79: 1390-1395.
11. Jasonni VM, D'Anna R, Mancuso A, et al. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy. Acta Obstet Gynecol Scand 2001; 80: 956-958.
12. Hilario S, Bozzini N, Borsari R, Baracat E. Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients. Fertil Steril 2009; 91: 240-243.
13. Fiscella K, Eisinger S, Meldrum S, et al. Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial. Obstet Gynecol 2006; 108: 1381-1387.
14. Esteve JLC, Acosta R, Heredia B, et al. Mifepristone for the treatment of uterine leiomyomas. Obstet Gynecol 2008; 112: 1029-1036.
15. Levens ED, Potlog-Nahari C, Armstrong AY, et al. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. Obstet Gynecol 2008; 111: 1129-1136.
16. Wilkens, J, Chwalisz K, Han C, et al. Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy. J Clin Endocrinol Metab 2008; 93: 4664-4671.
17. Goodwin S, Spies J, Worthington-Kirsch R, et al. Uterine artery embolization for treatment of uterine leiomyomata: long-term outcomes from the FIBROID registry. Obstet Gynecol 2008; 111: 22-33.
18. Pron G, Cohen M, Soucie J, et al. The Ontario Uterine Fibroid Embolization Trial. Part A. Baseline patient characteristics, fibroid burden, and impact on life. Fertil Steril 2003; 79: 112-119.
19. Pron G, Bennett J, Common A, et al. The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril 2003; 79: 120-127.
20. Hehenkamp WJK, Volkers NA, Birnie E, et al. EMMY trial: a randomized comparison of uterine artery embolization and hysterectomy for the treatment of symptomatic uterine fibroids. Int Congr Ser 2005; 1279: 179-183.
21. Hehenkamp WJK, Volkers NA, Donderwinkel PRJ, et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and postprocedural results from a randomized controlled trial. Am J Obstet Gynecol 2005; 193: 1618-1629.
22. Volkers NA, Hehenkamp WJK, Birnie E, et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. Am J Obstet Gynecol 2007; 196: 519e.1-519.e11.
23. Hehenkamp WJ, Volkers NA, Birnie E, et al. Symptomatic uterine fibroids: treatment with uterine artery embolization or hysterectomy-results from randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology 2008; 246: 823-832.
24. Ustunsoz B, Sahin Ugurel M, Bozlar U, et al. Is uterine artery embolization prior to myomectomy for giant fibroids helpful? Diagn Interv Radiol 2007; 13: 210-212.
25. Stewart EA, Rabinovici J, Tempany CMC, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006; 85: 22-29.
26. Mikami K, Murakami T, Okada A, et al. Magnetic resonance imaging-guided focused ultrasound ablations of uterine fibroids: early clinical experience. Radiat Med 2008; 26: 198-205.
27. Morita Y, Ito N, Hikida H, et al. Noninvasive magnetic resonance imaging-guided focused ultrasound treatment for uterine fibroids-early experience. Eur J Obstet Gynecol Reprod Biol 2008; 139: 199-203.
28. Cho HH, Kim J, Kim M. Transvaginal radiofrequency thermal ablation: a day-care approach to symptomatic uterine myomas. Aust N Z J Obstet Gynecol 2008; 48: 296-301.
29. Ghezzi F, Cromi A, Bergamini V, et al. Midterm outcome of radiofrequency thermal ablation for symptomatic uterine myomas. Surg Endosc 2007; 21: 2081-2085.
30. Luo X, Shen Y, Song W, et al. Pathologic evaluation of uterine leiomyoma treated with radiofrequency ablation. Int J Gynecol Obstet 2007; 99: 9-13.
31. Recaldini C, Carrafiello G, Lagana D, et al. Percutaneous sonographically guided radiofrequency ablation of medium-sized fibroids: feasibility study. AJR Am J Roentgenol 2007; 189: 1303-1306.
32. Bergamini V, Ghezzi F, Cromi A, et al. Laparoscopic radiofrequency thermal ablation: a new approach to symptomatic uterine myomas. Am J Obstet Gynecol 2005; 192: 768-773.
33. Plotti G, Plotti F, Di Giovanni A, et al. Feasibility and safety of vaginal myomectomy: a prospective pilot study. J Minim Invasive Gynecol 2008; 15: 166-171.
34. Rossetti A, Sizzi O, Soranna L, et al. Long-term results of laparoscopic myomectomy: recurrence rate in comparison with abdominal myomectomy. Hum Reprod 2001; 16: 770-774.
35. Glasser M. Minilaparotomy myomectomy: a minimally invasive alternative to for the large fibroid uterus. J Minim Invasive Gynecol 2005; 12: 275083.
36. Palomba S, Zupi E, Russo T, et al. A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: short-term outcomes. Fertil Steril 2007; 88: 942-951.
37. Wen KC, Sung PL, Chao KC, et al. A prospective short-term evaluation of uterine leiomyomas treated by myomectomy through conventional laparotomy or ultraminilaparotomy. Fertil Steril 2008; 90: 2361-2366.
38. Moss JG, Edwards RD, Lumsden MA, et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids: the REST investigators. N Engl J Med 2007; 356: 360-370.
39. Broder MS, Goodwin S, Chen G, et al. Comparison of long-term outcomes of myomectomy and uterine artery embolization. Obstet Gynecol 2002; 100:864-868.
40. Goodwin SC, Bradley LD, Lipman JC, et al. Uterine artery embolization versus myomectomy: a multicenter comparative study. Fertil Steril 2006; 85: 14-21.
41. Mara M, Maskova J, Fucikova Z, et al. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroids embolization and myomectomy. Cardiovasc Intervent Radiol 2008; 31: 73-85.
42. Palomba S, Zupi E, Falbo A, et al. A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: reproductive outcomes. Fertil Steril 2007; 88: 933-941.